Avanos Medical Inc AVNS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference
-
GAME READY® Announces Partnership with NFL Defensive End and 49ers Star Nick Bosa
-
Avanos Medical, Inc. Announces Second Quarter 2024 Results
-
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
Trading Information
- Previous Close Price
- $23.02
- Day Range
- $23.09–23.48
- 52-Week Range
- $17.24–25.36
- Bid/Ask
- $22.58 / $23.75
- Market Cap
- $1.07 Bil
- Volume/Avg
- 166,551 / 222,020
Key Statistics
- Price/Earnings (Normalized)
- 19.64
- Price/Sales
- 1.58
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 2.63%
Company Profile
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,771
- Website
- https://www.avanos.com
Comparables
Valuation
|
Metric
|
AVNS
|
603301
|
02291
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.64 | 24.38 | 25.91 |
Price/Book Value | 0.87 | 1.18 | 3.30 |
Price/Sales | 1.58 | 1.68 | 14.99 |
Price/Cash Flow | 17.83 | 10.16 | — |
Price/Earnings
AVNS
603301
02291
Financial Strength
|
Metric
|
AVNS
|
603301
|
02291
|
|---|---|---|---|
Quick Ratio | 1.03 | 1.57 | 5.23 |
Current Ratio | 2.28 | 2.24 | 5.61 |
Interest Coverage | 1.60 | 5.28 | 1,176.00 |
Quick Ratio
AVNS
603301
02291
Profitability
|
Metric
|
AVNS
|
603301
|
02291
|
|---|---|---|---|
Return on Assets (Normalized) | 1.24% | 1.65% | 10.75% |
Return on Equity (Normalized) | 1.70% | 2.34% | 11.48% |
Return on Invested Capital (Normalized) | 1.89% | 1.91% | 10.45% |
Return on Assets
AVNS
603301
02291
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Bdctgmbgg | Lslby | $196.0 Bil | |||
| Stryker Corp
SYK
| Bbcdnwzlr | Zsxb | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Svsczfsr | Grszqcp | $124.5 Bil | |||
| Medtronic PLC
MDT
| Cslptrns | Sctlfz | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Mfnpmyrfyc | Jwtbxs | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Vmy | Gfqnc | $30.2 Bil | |||
| DexCom Inc
DXCM
| Jqpxhvwq | Ygjb | $27.3 Bil | |||
| Steris PLC
STE
| Dfxksjfq | Szxjvp | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bphgpfkgp | Hcrq | $21.3 Bil | |||
| Insulet Corp
PODD
| Bjtdqblhq | Ssblhd | $16.1 Bil |
United States